Page last updated: 2024-08-26

bosentan anhydrous and Cholera Infantum

bosentan anhydrous has been researched along with Cholera Infantum in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Birnboeck, H; Eggers, H; Hopfgartner, G; Jonkman, JH; Meyer, J; Schmitt, R; van Marle, S; Viischer, HW; Weber, C1

Trials

1 trial(s) available for bosentan anhydrous and Cholera Infantum

ArticleYear
Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:7

    Topics: Administration, Oral; Antihypertensive Agents; Area Under Curve; Blood Pressure; Bosentan; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Gastrointestinal Diseases; Headache; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Sulfonamides; Systole

1999